DEVELOPMENT OF A LONG-ACTING LIDOCAINE FORMULATION FOR THE TREATMENT OF INTERSTITIAL CYSTITIS/BLADDER PAIN SYNDROME

$3,265,321FY2018Defense Health AgencyDOD

Alivio Therapeutics Inc

Investigators